Literature DB >> 7686657

Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias.

N Twidale1, K Sutton, L Bartlett, A Dooley, S Winstanley, W Heddle, R Hassam, H Koutsounis.   

Abstract

Patients with atrial fibrillation or atrial flutter (AF) are candidates for radiofrequency (RF) catheter ablation of the atrioventricular (AV) node with the aim being to control heart rate. As patients with AF can have markedly impaired ventricular function, information concerning the hemodynamic effects of AV node ablation using RF current would be valuable. Fourteen consecutive patients (mean age 65 +/- 3 years) with drug-resistant AF underwent AV node catheter ablation with RF current and had permanent pacemaker implantation. The mean left ventricular ejection fraction (EF) by two-dimensional echocardiography immediately before ablation was 42 +/- 3% (range 14%-54%) and their mean exercise time was 4.4 +/- 0.4 minutes. Complete AV block was achieved in all 14 patients with 6 +/- 2 RF applications (range 1-18). There was no evidence of any acute cardiodepressant effect associated with delivery of RF current, and EF 3 days after ablation was 44 +/- 4%. By 6 weeks after ablation, the left ventricular EF was significantly improved compared to baseline (47 +/- 4% postablation vs 42 +/- 3% preablation; P < 0.05), and this modest increase in EF was accompanied by an improvement in exercise time (5.4 +/- 0.4 min). In conclusion, delivery of RF current for AV node catheter ablation in patients with AF and reduced ventricular function is not associated with any acute cardiodepressant effect. On the contrary, improved control of rapid heart rate following successful AV node ablation is associated with a modest and progressive improvement in cardiac performance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686657     DOI: 10.1111/j.1540-8159.1993.tb01714.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  21 in total

1.  Temporal trends in permanent pacemaker implantation: a population-based study.

Authors:  Daniel Z Uslan; Imad M Tleyjeh; Larry M Baddour; Paul A Friedman; Sarah M Jenkins; Jennifer L St Sauver; David L Hayes
Journal:  Am Heart J       Date:  2008-02-19       Impact factor: 4.749

2.  Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias.

Authors:  A G Manolis; A G Katsivas; E E Lazaris; C V Vassilopoulos; N E Louvros
Journal:  J Interv Card Electrophysiol       Date:  1998-03       Impact factor: 1.900

3.  Atrial fibrillation: the last challenge in interventional electrophysiology.

Authors:  F D Murgatroyd; A J Camm
Journal:  Br Heart J       Date:  1995-09

4.  Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study.

Authors:  T Levy; S Walker; M Mason; P Spurrell; S Rex; S Brant; V Paul
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

5.  Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation.

Authors:  M Edner; K Caidahl; L Bergfeldt; B Darpö; N Edvardsson; M Rosenqvist
Journal:  Br Heart J       Date:  1995-09

6.  Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.

Authors:  Osmar Antonio Centurión; Karina Elizabeth Scavenius; Laura B García; Luis Miño; Judith Torales; Orlando Sequeira
Journal:  J Atr Fibrillation       Date:  2018-06-30

Review 7.  Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia.

Authors:  Jonathan Weinstock; Paul J Wang; Munther K Homoud; Mark S Link; N A Mark Estes
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

Review 8.  Heart failure and tachycardia-induced cardiomyopathy.

Authors:  Ethan R Ellis; Mark E Josephson
Journal:  Curr Heart Fail Rep       Date:  2013-12

9.  The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.

Authors:  G N Kay; K A Ellenbogen; M Giudici; M M Redfield; L S Jenkins; M Mianulli; B Wilkoff
Journal:  J Interv Card Electrophysiol       Date:  1998-06       Impact factor: 1.900

Review 10.  [Pacemaker therapy in patients with atrial fibrillation].

Authors:  A Schuchert; T Meinertz
Journal:  Herz       Date:  1998-06       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.